Viewing Study NCT06716905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-05-26 @ 8:25 AM
Study NCT ID: NCT06716905
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2024-11-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-alcoholic Steatohepatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-alcoholic Steatohepatitis View
None ACT500 View
None NM6606 View
None pharmacokinetic View